DUBLIN, Nov. 20, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/f8pddr/hemodialysis_and) has announced the addition of the "Hemodialysis & Peritoneal Dialysis Market Products, Modality (Nocturnal, APD, & CAPD), End-users - Global Forecast to 2020" report to their offering.
"Hemodialysis & Peritoneal Dialysis Market Products (Machine, Dialyzer, Bloodlines, Concentrates, Catheters, Transfer Sets, Water Treatment Systems, & Services), Modality (Nocturnal, APD, & CAPD), End-users (In-center & Home) - Global Forecast to 2020|"
The global hemodialysis & peritoneal dialysis market is valued at USD 69.45 Billion in 2015 and is expected to reach USD 93.83 Billion by 2020, at a CAGR of 6.2% from 2015 to 2020. A number of factors such as the increasing number of ESRD patients and the rising prevalence of diabetes and hypertension are driving the growth of the global hemodialysis & peritoneal dialysis market. Furthermore, growth in the number of dialysis facilities in developed as well as developing economies, growth in aging population, and increasing private investments and venture funding to support new product development are some of the other factors that are propelling the growth of the dialysis products and services market. In addition, increasing adoption of new treatment modalities such as home hemodialysis and nocturnal dialysis is further fuelling the growth of hemodialysis & peritoneal dialysis market.
However, a few pivotal factors such as the reduction in Medicare reimbursements to dialysis centers, low awareness about kidney diseases and their treatment modalities, product recalls, stringent regulatory policies for the approval of new dialysis products, and poor reimbursement scenario in developing countries are hindering the growth of this market. Moreover, high competition among market players, high procedural cost, and low cost of kidney transplantation are the foremost challenges faced by industry players.
The global hemodialysis & peritoneal dialysis market is dominated by North America, followed by Asia-Pacific, Europe, and Rest of the World (RoW). However, the Asia-Pacific region is expected to grow at the highest CAGR of -9.7% from 2015 to 2020. Over the next five years, the growth of the dialysis products and services market in the Asia-Pacific region is likely to be centered at China, and India. A number of factors such as the huge patient population base, increasing number of dialysis centres, improving reimbursement and insurance scenario, and increasing government initiatives to develop dialysis facilities are driving the growth of the hemodialysis & peritoneal dialysis market in the Asia-Pacific region.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Competitive Intelligence Analysis
7 Industry Insights
8 Adoption of Dialysis Modalities, By Procedural Volume
9 Global Hemodialysis Market
10 Global Peritoneal Dialysis Market
11 Global Dialysis Market, By End User
12 Global Dialysis Market, By Region
13 Competitive Landscape
14 Company Profiles
- Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
- B. Braun Melsungen Ag
- Baxter International Inc.
- Davita Healthcare Partners Inc.
- Diaverum Deutschland Gmbh
- Fresenius Medical Care Ag & Co. Kgaa
- Mar Cor Purification, Inc. (A Cantel Medical Company)
- Nikkiso Co., Ltd.
- Nipro Corporation
- Nxstage Medical, Inc.
For more information visit http://www.researchandmarkets.com/research/f8pddr/hemodialysis_and
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
